ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 1 filers reported holding ACCELERON PHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $46,689,000 | +435.4% | 271,291 | +290.4% | 0.04% | +425.0% |
| Q2 2021 | $8,721,000 | -12.1% | 69,496 | -5.0% | 0.01% | -20.0% |
| Q1 2021 | $9,923,000 | +25.2% | 73,175 | +18.1% | 0.01% | +42.9% |
| Q4 2020 | $7,926,000 | -35.8% | 61,949 | -43.5% | 0.01% | -46.2% |
| Q3 2020 | $12,347,000 | -10.4% | 109,722 | -24.2% | 0.01% | -18.8% |
| Q2 2020 | $13,785,000 | -29.9% | 144,686 | -33.9% | 0.02% | -48.4% |
| Q1 2020 | $19,670,000 | +3077.7% | 218,866 | +1924.5% | 0.03% | +3000.0% |
| Q3 2018 | $619,000 | +13.2% | 10,811 | -4.2% | 0.00% | 0.0% |
| Q2 2018 | $547,000 | -26.4% | 11,282 | -40.6% | 0.00% | 0.0% |
| Q1 2018 | $743,000 | -37.9% | 19,000 | -46.0% | 0.00% | -50.0% |
| Q2 2016 | $1,196,000 | +26.4% | 35,205 | -1.8% | 0.00% | 0.0% |
| Q1 2016 | $946,000 | -52.0% | 35,858 | -11.3% | 0.00% | -33.3% |
| Q4 2015 | $1,972,000 | +113.4% | 40,440 | +38.5% | 0.00% | +200.0% |
| Q2 2015 | $924,000 | +33.5% | 29,190 | +60.4% | 0.00% | 0.0% |
| Q1 2015 | $692,000 | -47.4% | 18,193 | -46.1% | 0.00% | -50.0% |
| Q4 2014 | $1,316,000 | +73.4% | 33,779 | +51.1% | 0.00% | +100.0% |
| Q2 2014 | $759,000 | -82.2% | 22,352 | -81.9% | 0.00% | -83.3% |
| Q1 2014 | $4,271,000 | – | 123,801 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 938,490 | $120,070,000 | 33.50% |
| Foresite Capital Management III, LLC | 108,630 | $13,898,000 | 16.15% |
| Octagon Capital Advisors LP | 112,363 | $14,376,000 | 4.98% |
| Artal Group S.A. | 1,400,000 | $179,116,000 | 3.84% |
| Avoro Capital Advisors LLC | 1,550,000 | $198,307,000 | 3.42% |
| Affinity Asset Advisors, LLC | 45,000 | $5,757,000 | 3.05% |
| NWI MANAGEMENT LP | 200,000 | $25,588,000 | 2.54% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 71,000 | $9,063,000 | 2.48% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,600,000 | $332,644,000 | 2.00% |
| Parkman Healthcare Partners LLC | 52,458 | $6,711,000 | 1.72% |